Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research.
EAU26: prostate cancer screening compares favourably compared to breast cancer in identifying significant cancers and reducing mortality.
HRR mutations are commonly of germline origin, with several real world studies suggesting a 23-44% probability of an HRR alteration to be of germline origin: 1 The following summarizes recommendations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results